LAZZARICH, Elisa
LAZZARICH, Elisa
Anti-phospholipid nephropathy only belongs to Myakis I and IIA classes, always in association with lupus anticoagulant, but never anti-b(2)GP1 antibodies.
2013-01-01 Izzo, C; Quaglia, Marco; Radin, E; Airoldi, A; Fenoglio, R; Lazzarich, Elisa; Stratta, Piero
Clinical hypothesis predicts renal pathology in 67% of renal diseases: a 30-year experience on 1288 renal biopsies.
2006-01-01 Stratta, Piero; Quaglia, Marco; Marengo, M; Ciccone, G; Mesiano, P; Lazzarich, Elisa; Besso, L; Fenoglio, R; Canavese, C; Fop, F; Mazzucco, G.
Conversion to rapamycin in renal transplanted patients who develop cancer: preliminary observation on a monocentric experience.
2006-01-01 Quaglia, Marco; Barbè, Mc; Morellini, V; Brustia, M; Lazzarich, Elisa; Turello, E; Cornella, C; Fenoglio, R; Stratta, Piero
Is plamapheresis effective to prevent FSGS recurrence on transplanted kidney?
2006-01-01 Quaglia, Marco; Palmieri, D; Turello, E; Lazzarich, Elisa; Morellini, V; Cofano, F; Giraudi, R; Messina, M; Zennaro, C; Carraro, M; Stratta, Piero
MGUS in renal transplant: still a matter of conern?
2013-01-01 Fenoglio, R; Lazzarich, Elisa; Cagna, D; Cena, Tiziana; Conti, N; Quaglia, Marco; Radin, E; Izzo, C; Stratta, Piero
Prophylactic perioperative plasmapheresis does not prevent rebound of permeability factors in patients with focal segmental glomerulosclerosis (FSGS) who undergo kidney transplant.
2005-01-01 Quaglia, Marco; Turello, E; Morellini, V; Lazzarich, Elisa; Palmieri, D; Canavese, C; Zennaro, C; Carraro, M; Stratta, Piero
Risk factors for kidney graft loss: the role of HCV infection in 400 consecutive cases.
2007-01-01 Lazzarich, Elisa; Turello, E; Musetti, Claudio; Palmieri, D; Gravellone, L; Quaglia, Marco; Fenoglio, R; Cena, Tiziana
Unexpectedly high prevalence of critic coronary artery disease in asymptomatic dialysis patients screened for transplant wait list.
2015-01-01 Battista, M.; Rossi, L.; Musetti, Claudio; Lazzarich, Elisa; Cornella, C.; Quaglia, Marco; Stratta, Piero
Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy.
2014-01-01 Quaglia, Marco; Musetti, Claudio; Ghiggeri, G. M.; Fogazzi, G. B.; Settanni, F.; Boldorini, Renzo Luciano; Lazzarich, Elisa; Airoldi, A.; Izzo, C.; Giordano, Mara; Stratta, Piero
Warning: standard doses of low molecular weight heparin exceed the upper threshold of the anti-Xa range according to the degree of renal failure.
2007-01-01 Fenoglio, R; Quaglia, Marco; Karvela, E; Lazzarich, Elisa; Cofano, F; Cena, Tiziana; Musetti, Claudio; Pergolini, P; Canavese, C; Bellomo, Giorgio; Stratta, Piero
Why have outcomes of lupus nephritis been improving over the last 40 years? A monocentric experience.
2013-01-01 Quaglia, Marco; Radin, E; Izzo, C; Airoldi, A; Lazzarich, Elisa; Fenoglio, R; Stratta, Piero
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti-phospholipid nephropathy only belongs to Myakis I and IIA classes, always in association with lupus anticoagulant, but never anti-b(2)GP1 antibodies. | 1-gen-2013 | Izzo, C; Quaglia, Marco; Radin, E; Airoldi, A; Fenoglio, R; Lazzarich, Elisa; Stratta, Piero | |
| Clinical hypothesis predicts renal pathology in 67% of renal diseases: a 30-year experience on 1288 renal biopsies. | 1-gen-2006 | Stratta, Piero; Quaglia, Marco; Marengo, M; Ciccone, G; Mesiano, P; Lazzarich, Elisa; Besso, L; Fenoglio, R; Canavese, C; Fop, F; Mazzucco, G. | |
| Conversion to rapamycin in renal transplanted patients who develop cancer: preliminary observation on a monocentric experience. | 1-gen-2006 | Quaglia, Marco; Barbè, Mc; Morellini, V; Brustia, M; Lazzarich, Elisa; Turello, E; Cornella, C; Fenoglio, R; Stratta, Piero | |
| Is plamapheresis effective to prevent FSGS recurrence on transplanted kidney? | 1-gen-2006 | Quaglia, Marco; Palmieri, D; Turello, E; Lazzarich, Elisa; Morellini, V; Cofano, F; Giraudi, R; Messina, M; Zennaro, C; Carraro, M; Stratta, Piero | |
| MGUS in renal transplant: still a matter of conern? | 1-gen-2013 | Fenoglio, R; Lazzarich, Elisa; Cagna, D; Cena, Tiziana; Conti, N; Quaglia, Marco; Radin, E; Izzo, C; Stratta, Piero | |
| Prophylactic perioperative plasmapheresis does not prevent rebound of permeability factors in patients with focal segmental glomerulosclerosis (FSGS) who undergo kidney transplant. | 1-gen-2005 | Quaglia, Marco; Turello, E; Morellini, V; Lazzarich, Elisa; Palmieri, D; Canavese, C; Zennaro, C; Carraro, M; Stratta, Piero | |
| Risk factors for kidney graft loss: the role of HCV infection in 400 consecutive cases. | 1-gen-2007 | Lazzarich, Elisa; Turello, E; Musetti, Claudio; Palmieri, D; Gravellone, L; Quaglia, Marco; Fenoglio, R; Cena, Tiziana | |
| Unexpectedly high prevalence of critic coronary artery disease in asymptomatic dialysis patients screened for transplant wait list. | 1-gen-2015 | Battista, M.; Rossi, L.; Musetti, Claudio; Lazzarich, Elisa; Cornella, C.; Quaglia, Marco; Stratta, Piero | |
| Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy. | 1-gen-2014 | Quaglia, Marco; Musetti, Claudio; Ghiggeri, G. M.; Fogazzi, G. B.; Settanni, F.; Boldorini, Renzo Luciano; Lazzarich, Elisa; Airoldi, A.; Izzo, C.; Giordano, Mara; Stratta, Piero | |
| Warning: standard doses of low molecular weight heparin exceed the upper threshold of the anti-Xa range according to the degree of renal failure. | 1-gen-2007 | Fenoglio, R; Quaglia, Marco; Karvela, E; Lazzarich, Elisa; Cofano, F; Cena, Tiziana; Musetti, Claudio; Pergolini, P; Canavese, C; Bellomo, Giorgio; Stratta, Piero | |
| Why have outcomes of lupus nephritis been improving over the last 40 years? A monocentric experience. | 1-gen-2013 | Quaglia, Marco; Radin, E; Izzo, C; Airoldi, A; Lazzarich, Elisa; Fenoglio, R; Stratta, Piero |